NKG2D-based CAR T-cell immunotherapy of solid tumours.

Name: NKG2D-based CAR T-cell immunotherapy of solid tumours.
Start: 2026-11-19T14:40
End: 2026-11-19T14:55
Location: ExCeL London

London Biotechnology Show 2026 · 19 November 2026 · 14:40–14:55 · Main Conference

NKG2D-based CAR T-cell immunotherapy of solid tumours. was a session at London Biotechnology Show 2026 on 19 November 2026 in London, with 1 speaker on record.

Speakers

John Maher — Speaker CSO, Leucid Bio